0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Invited Commentary  | 
Precision Medicine in Breast Cancer Care An Early Glimpse of Impact
Allison W. Kurian, MD, MSc; Christopher R. Friese, PhD, RN
JAMA Oncology
Original Investigation  | 
Association Between Use of the 21-Gene Recurrence Score Assay and Receipt of Chemotherapy Among Medicare Beneficiaries With Early-Stage Breast Cancer, 2005-2009
Michaela A. Dinan, PhD; Xiaojuan Mi, PhD; Shelby D. Reed, PhD; et al.
JAMA Oncology
Original Investigation  | 
Risk of Critical Illness Among Patients With Solid Cancers A Population-Based Observational Study
Kathryn Puxty, MBChB; Philip McLoone, BSc; Tara Quasim, MD; et al.
JAMA Oncology
Editorial  | 
Rethinking the Standard for Ductal Carcinoma In Situ Treatment
Laura Esserman, MD, MBA; Christina Yau, PhD